openPR Logo
Press release

Antiviral Drugs Market Size, Sales, Share, Analysis, Industry Demand and Forecasts Report From 2019-2025

05-03-2021 02:45 PM CET | Health & Medicine

Press release from: iCognition Insights Pvt. Ltd.

Antiviral Drugs Market

Antiviral Drugs Market

The global antiviral drugs market size was USD 55.91 billion in 2019 and is projected to reach USD 64.9 billion by 2025, registering a CAGR of 2.5% during the forecast period.

This global report by iCognition Insights provides a detail market analysis of the antiviral drugs market by Drug Class (Reverse Transcriptase Inhibitors, DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Protease Inhibitors), by Type (Generic, Branded), by Application (Hepatitis, HIV, Influenza, Herpes), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Rise in the number of cases of viral infections such as hepatitis, influenza, coronavirus, and human immunodeficiency virus (HIV) is a key driver for the growth of this market.

Download sample copy of this report: https://www.icognitioninsights.com/product/antiviral-drugs-market-analysis-by-drug-class/

COVID-19 impact and deviation analysis: This report includes an exclusive section on the COVID-19 impact and deviation analysis with in-depth insights on prevalence, key market trends and market size deviation analysis (2020-2025). Our domain experts combined with experienced market analysts take continuous efforts to discover contextually relevant insights from the data to provide you structured and reliable insights and help you sustain and sail through the pandemic wave.

In 2019, the reverse transcriptase inhibitors segment commanded the maximum revenue share.

Based on the research by iCognition Insights research and analysis experts, the reverse transcriptase inhibitors segment will continue to grow at the faster CAGR followed by the DNA polymerase inhibitors segment which is expected to see a significant growth during the forecast period till 2025.

Rising consumer perception towards high quality branded medicines to drive the growth for branded antiviral drugs.

In 2019, based on type, the branded segment accounted for the maximum revenue share owing to the rising consumer perception towards this segment. However, generics antiviral drugs segment is anticipated to show an accelerated growth due to the increasing awareness about the benefits associated with the adoption of generic medicine.

Hepatitis application segment to dominate the market during the forecast period.

Increasing prevalence and incidences of varied types of hepatitis is set to drive the market. Moreover, the antiviral drugs market is also set to gain momentum from HIV segment owing to its large patient base worldwide.

Asia-Pacific is projected to record the fastest CAGR over the forecast period.

Rising prevalence of viral infections, improving healthcare sector & policies, and active research & development engagements will foster the growth in the Asia-Pacific region. The North American market is expected to maintain the largest share of the global market, attributed by the advanced healthcare infrastructure, presence of large number of pharmaceutical & biotechnology firms, and rising awareness initiatives by the government.

Learn more about the key questions addressed in this decision-intelligence report: https://www.icognitioninsights.com/product/antiviral-drugs-market-analysis-by-drug-class/#1609849655948-15082c58-b100

Key market players: Bristol Myers Squibb (U.S.), Gilead Sciences, Inc. (U.S.), Cipla Limited (U.S.), F. Hoffmann-La Roche AG (Switzerland), Aurobindo Pharma Limited (India), AbbVie Inc. (U.S.), Dr. Reddy’s Laboratories (India), Merck & Co., Inc. (U.S.), Johnson & Johnson (U.S.), and GlaxoSmithKline plc (U.K.).

Research Methodology: All the decision-intelligence reports are developed by implementing proprietary domain-assisted cognition (DAC) research framework that combines gathering precise market information via primary and secondary research, discovering context and relevance, data analysis, quality audit and insights discovery.

Table of Content :

Research Methodology

Market Summary

Market Dynamics

Industry Outlook
Covid-19 Impact and Deviation Analysis
Antiviral Drugs Market Size and Forecast, by Drug Class (2017-2025), USD Million
Reverse Transcriptase Inhibitors (RTI)
DNA Polymerase Inhibitors (DPI)
Neuraminidase Inhibitors (NI)
Protease Inhibitors (PI)
Others

Antiviral Drugs Market Size and Forecast, by Drug Type (2017-2025), USD Million
Branded
Generics

Antiviral Drugs Market Size and Forecast, by
Application (2017-2025), USD Million
Hepatitis
HIV
Influenza
Herpes
Others

Regional Analysis (2017-2025), USD Million
North America (U.S., Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Rest of Europe)
Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)

Competitor Analysis

Company Profiles

Contact Us:
iCognition Insights
U.S: +1 617 676 0160
APAC: +81 503 196 4844
Email: info@icognitioninsights.com

About iCognition Insights:

iCognition Insights is a global market intelligence and market research services firm, specialized in providing industry-standard syndicated reports and consulting services to global clients across life sciences and healthcare industry verticals. Our methodological research approach coupled with deep domain and analytical expertise opens the doors to the insights that really matter.

With over 20+ years of combined industry experience, we assist our clients in chalking their strategic growth plans and make informed business decisions. Our proprietary research and analysis framework enables our clients discover hidden insights and granular quantitative and qualitative information on the market, technology, or company of interest.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drugs Market Size, Sales, Share, Analysis, Industry Demand and Forecasts Report From 2019-2025 here

News-ID: 2278673 • Views: 365

More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug